Quantcast

Industry news that matters to you.  Learn more

Covance Scientists to Present at the Molecular Med Tri-Con

Reading time: 3 – 5 minutes

Scientists from Covance Discovery and Translational Services will be showcasing their company’s R&D capabilities, talent and technologies in biomarkers, discovery services, genomics and proteomics to over 3,000 participants at the 2012 Molecular Med Tri-Con this week in San Francisco, CA.

The Molecular Med Tri-Con is a unique conference that brings together the therapeutic and diagnostic aspects of the life sciences industry in one place with access to over 3,000 delegates from 1,200 companies. Spanning five days (Sun 2/19 – Thurs 2/23), the event includes 12 core programs, 450+ presentations, 60+ posters and 140+ exhibitors.

Covance Discovery and Translational Services, which integrates the company’s Antibody Products, Biomarker Center of Excellence, Discovery Services, Genomics Laboratory and Immunology Services, was created in 2010 to offer clients a depth and breadth of drug discovery and biomarker services unmatched in the CRO industry.

Scientists from the Biomarker Center of Excellence, Discovery Services, the Covance Genomics Laboratory and Antibody Products will be available at the conference to discuss the company’s spectrum of services and expertise, including Covance’s new BioPathways resource, which enables scientists to search biological and disease pathways and rapidly identify validated assays and commercially available antibodies.

Covance and Ingenuity to demo new tools in next gen sequencing

This year at the Molecular Med Tri-Con, Covance, which offers comprehensive and fully integrated genomics services to provide clients the highest quality data and ease of use from sample acquisition to actionable results, and Ingenuity Systems, a leading provider of information & analytics solutions for life science researchers, will demonstrate the latest tools in next-generation sequencing data analysis. Covance and Ingenuity will demonstrate Ingenuity Variant Analysis, a web application that helps researchers studying human disease to identify causal variants from human resequencing data in just minutes. Come learn how the Covance and Ingenuity partnership can provide you a combination of high quality genomics data and innovative tools for data interpretation.

Date: Tuesday, February 21st, 12:40 pm – 4:20 pm
Location: Moscone North Convention Center, Room 114

Covance and Affymetrix lunch seminar

Also on Tuesday, a Covance and Affymetrix lunch seminar will feature two speakers discussing the clinical applications of pharmacogenomics:

  • Mark Parrish, Senior Manager of Assay Development and the Covance Genomics Laboratory will discuss clinical applications of pharmacogenomics and present on high-throughput DMET profiling for drug development.
  • William Douglas Figg Sr., Pharm.D., M.B.A, Senior Scientist and Head of the Clinical Pharmacology Program and Molecular Pharmacology Section, Medical Oncology Branch and the Center for Cancer Research, National Cancer Institute and National Institutes of Health, will talk about moving pharmacogenetics from the laboratory to the clinic.

Date: Tuesday, February 21st, 12:40 pm – 1:40 pm
Location: Diagnostics Channel, Genomic Screening & Diagnosis of Human Diseases Track

Covance scientists to present four posters

This year, four scientists from Covance Discovery and Translational Services will be presenting posters, discussing data mining, biomarker discovery, whole exome sequencing, and miRNA extraction.

  • Mining PubMed for Biomarker-Disease Associations to Guide Discovery
    Walter J. Jessen, Ph.D., Covance Biomarker Center of Excellence
  • Optimizing Therapeutic Outcomes for Glioblastoma Multiforme Leveraging Whole Exome Sequencing
    Anup Madan, Ph.D., Covance Genomics Laboratory
  • Mapping the Molecular Genomic Network of Glioblastoma Multiforme
    Anup Madan, Ph.D., Covance Genomics Laboratory
  • Optimization of miRNA Extraction from Serum
    Zinaida Sergueeva, Ph.D., Covance Genomics Laboratory

Covance scientific experts available to discuss drug discovery and biomarker services

Attendees at the 2012 Molecular Med Tri-Con can also visit booth 206/208 in the Exhibit Hall and register to win an Apple iPad. Scientific experts in biomarkers, companion diagnostics, computational biology, discovery services, genomics, oncology studies and translational medicine will be available to discuss how Covance can help their clients make faster and more effective decisions about their portfolios.

Source: Covance Discovery and Translational Services